Katie Porter said...
It is to profit their shareholders. And I want them to be honest about that because then we can begin having a debate about what to do about the cost of prescription drugs.
Context
Porter emphasizes the need for transparency in pharmaceutical pricing to address drug costs.
05/19/2021